Indication
Latent bejel
Latent bejel refers to the asymptomatic, clinically quiescent phase of endemic syphilis, a chronic nonvenereal treponematosis caused by the spirochete *Treponema pallidum* subspecies *endemicum*. Read more about Latent bejel
3 drugs 3 manufacturers
Drugs that treat it
Common Latent bejel therapies.
EXTENCILLINE (penicillin G benzathine)
BICILLIN L-A (penicillin G benzathine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonLatent bejel refers to the asymptomatic, clinically quiescent phase of endemic syphilis, a chronic nonvenereal treponematosis caused by the spirochete *Treponema pallidum* subspecies *endemicum*.
It primarily occurs in populations living in arid, rural regions of the Middle East and the Sahel, where primary and secondary mucocutaneous infections are typically acquired in childhood through skin-to-skin contact or shared utensils.
In this latent stage, active lesions involving the oral mucosa, skin, or bones have resolved, leaving patients entirely free of overt symptoms while remaining seropositive on nontreponemal and treponemal assays.
Pathophysiologically, the bacteria persist subclinically in deep tissues, carrying a long-term risk of reactivation into late, destructive tertiary disease marked by disfiguring gummatous lesions and periostitis of the bone and cartilage.
- nih.gov
Latent bejel refers to the asymptomatic, clinically quiescent phase of endemic syphilis, a chronic nonvenereal treponematosis caused by the spirochete *Treponema pallidum* subspecies *endemicum*
- wikipedia.org
Latent bejel refers to the asymptomatic, clinically quiescent phase of endemic syphilis, a chronic nonvenereal treponematosis caused by the spirochete *Treponema pallidum* subspecies *endemicum* In this latent stage, active lesions involving the oral mucosa, skin, or bones have resolved, leaving patients entirely free of overt symptoms while remaining seropositive on nontreponemal and treponemal assays Pathophysiologically, the bacteria persist subclinically in deep tissues, carrying a long-term...
- merckmanuals.com
It primarily occurs in populations living in arid, rural regions of the Middle East and the Sahel, where primary and secondary mucocutaneous infections are typically acquired in childhood through skin-to-skin contact or shared utensils In this latent stage, active lesions involving the oral mucosa, skin, or bones have resolved, leaving patients entirely free of overt symptoms while remaining seropositive on nontreponemal and treponemal assays Pathophysiologically, the bacteria persist subclinica...
- johnshopkins.edu
It primarily occurs in populations living in arid, rural regions of the Middle East and the Sahel, where primary and secondary mucocutaneous infections are typically acquired in childhood through skin-to-skin contact or shared utensils
- cdc.gov
In this latent stage, active lesions involving the oral mucosa, skin, or bones have resolved, leaving patients entirely free of overt symptoms while remaining seropositive on nontreponemal and treponemal assays
- nih.gov
Pathophysiologically, the bacteria persist subclinically in deep tissues, carrying a long-term risk of reactivation into late, destructive tertiary disease marked by disfiguring gummatous lesions and periostitis of the bone and cartilage
Personalize your experience
Follow Latent bejel and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.